HILLHURST BIOPHARMA COMPLETES SEED FINANCING TO ADVANCE CLINICAL DEVELOPMENT

SAN DIEGO, Dec. 20, 2023 /PRNewswire/ — Hillhurst Biopharmaceuticals, Inc. (“Hillhurst”), a clinical stage biopharmaceutical company focused on developing liquid drug products containing therapeutic gases, announced today the completion of a financing that, together with non-dilutive…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks